Aviamarin 50mg pills 10 pcs.


More info

Aviamarin 50mg pills 10 pcs.

pharmachologic effect
Blocks histamine H1 receptors and m-cholinergic receptors of the central nervous system. It inhibits the vestibular apparatus of the inner ear, acting primarily on the otoliths, in high doses - on the semicircular canals. The main effect of dimenhydrinate is due to the blockade of m-cholinergic receptors. It has an antiemetic, sedative effect, eliminates dizziness.


Sea and air sickness.
Prevention and treatment of symptoms of vestibular and labyrinth disorders (dizziness, nausea, vomiting), with the exception of symptoms caused by antitumor therapy.
Symptomatic therapy of Meniere's disease.


Hypersensitivity to dimenhydrinate or other components of the drug, children under 6 years old, breastfeeding period.

Use during pregnancy and lactation

Use of the drug during pregnancy is possible only if the expected benefit to the mother outweighs the potential risk to the fetus.

The use of the drug during breastfeeding is contraindicated. If necessary, use of the drug, breast-feeding should be discontinued.


1 tablet contains:

active substance:

Dimenhydrinate 50.0 mg;


microcrystalline cellulose 40.0 mg, povidone 4.0 mg, crospovidone 10.0 mg, mannitol 90.0 mg, colloidal silicon dioxide (Aerosil) 4.0 mg, magnesium stearate 2.0 mg.

Dosage and administration

Inside, before eating. For the prevention of motion sickness, the first dose should be taken 30-60 minutes before the start of the movement.

Children aged 6-12 years: 1 / 2-1 tablet (25-50 mg) every 6-8 hours, but not more than 3 pills (150 mg) for 24 hours.

Adults and children 12 years and older: 1-2 pills (50-100 mg) every 4-6 hours, but not more than 8 pills (400 mg) for 24 hours.

Side effects

The incidence of adverse reactions is as follows: very often (≥1 / 10 cases), often (≥1 / 100 and <1/10 cases), infrequently (≥1 / 1000 and <1/100 cases), rarely (≥1 / 10,000 and <1/1000 cases) and very rarely (<1/10000 cases, including individual messages).

From the side of the central nervous system: very often - dizziness, drowsiness, impaired concentration; often - general weakness, fatigue, anxiety, nervousness; rarely - headache, insomnia.

On the part of the senses: often - weakening of night and color vision, blurred vision, disturbed accommodation.

On the part of the digestive system: often - dry mouth, nausea, vomiting; very rarely - loss of appetite.

On the part of the respiratory system: infrequently - dryness of the mucous membrane of the nose and throat, thickening of bronchial secretions.

Since the cardiovascular system: rarely - lower blood pressure, tachycardia.

Allergic reactions: rarely - skin rash, medical dermatitis; very rarely - angioedema, bronchospasm.

From the urinary system: rarely - difficulty urinating.

Other: rarely - hemolytic anemia.

If any of the adverse reactions listed in the instructions are aggravated, or you notice any other adverse effects that are not listed in the instructions, inform your doctor.

Drug interaction

Dimenhydrinate enhances the action of atropine, tricyclic antidepressants, catecholamines, barbiturates, ethanol, sedatives and hypnotics, neuroleptics.
Dimenhydrinate reduces the effect of corticosteroids, anticoagulants.
Dimenhydrinate reduces the response to apomorphine.
Dimenhydrinate reduces the depressive effect of acetylcholine on the heart muscle.
Simultaneous administration of dimenhydrinate with bismuth preparations, scopolamine, anesthetics and psychotropic drugs increases the likelihood of visual impairment.
Simultaneous use of the drug with ototoxic antibiotics (streptomycin, neomycin, viomycin, amikacin, kanamycin) is not recommended, because digimhydrinate can mask the symptoms of ototoxicity and contribute to the development of irreversible hearing loss.

It is a pharmaceutical drug. Use only as directed by your doctor.